[HTML][HTML] Ten decadal advances in fungal biology leading towards human well-being

A Mapook, KD Hyde, K Hassan, BM Kemkuignou… - Fungal Diversity, 2022 - Springer
Fungi are an understudied resource possessing huge potential for developing products that
can greatly improve human well-being. In the current paper, we highlight some important …

Overcoming multidrug resistance in cancer: Recent progress in nanotechnology and new horizons

M Majidinia, M Mirza‐Aghazadeh‐Attari, M Rahimi… - IUBMB …, 2020 - Wiley Online Library
Multidrug resistance (MDR), defined as the ability of cancer cells to gain resistance to both
conventional and novel chemotherapy agents, is an important barrier in treating …

CRISPR/Cas9-engineered universal CD19/CD22 dual-targeted CAR-T cell therapy for relapsed/refractory B-cell acute lymphoblastic leukemia

Y Hu, Y Zhou, M Zhang, W Ge, Y Li, L Yang, G Wei… - Clinical Cancer …, 2021 - AACR
Purpose: Autologous chimeric antigen receptor T (CAR-T) cell therapy is an effective
treatment for relapsed/refractory acute lymphoblastic leukemia (r/r ALL). However, certain …

[HTML][HTML] GM2 gangliosidoses: clinical features, pathophysiological aspects, and current therapies

AF Leal, E Benincore-Flórez, D Solano-Galarza… - International journal of …, 2020 - mdpi.com
GM2 gangliosidoses are a group of pathologies characterized by GM2 ganglioside
accumulation into the lysosome due to mutations on the genes encoding for the β …

[HTML][HTML] Current and future prospects for gene therapy for rare genetic diseases affecting the brain and spinal cord

TL Jensen, CR Gøtzsche… - Frontiers in molecular …, 2021 - frontiersin.org
In recent years, gene therapy has been raising hopes toward viable treatment strategies for
rare genetic diseases for which there has been almost exclusively supportive treatment. We …

[HTML][HTML] Off-target analysis in gene editing and applications for clinical translation of CRISPR/Cas9 in HIV-1 therapy

A Atkins, CH Chung, AG Allen, W Dampier… - Frontiers in genome …, 2021 - frontiersin.org
As genome-editing nucleases move toward broader clinical applications, the need to define
the limits of their specificity and efficiency increases. A variety of approaches for nuclease …

COVID-19: clinical presentation and detection methods

M Pradhan, K Shah, A Alexander… - … of Immunoassay and …, 2022 - Taylor & Francis
The unending outburst of COVID-19 has reinforced the necessity of SARS-CoV-2
identification approaches for the prevention of infection transmission and the proper care of …

GLP-1 receptor agonists synergize with DYRK1A inhibitors to potentiate functional human β cell regeneration

C Ackeifi, P Wang, E Karakose… - Science translational …, 2020 - science.org
Glucagon-like peptide-1 receptor (GLP1R) agonists and dipeptidyl peptidase 4 inhibitors are
widely prescribed diabetes drugs due to their ability to stimulate insulin secretion from …

Clustered regularly interspaced short palindromic repeats (CRISPR) technology and genetic engineering strategies for microalgae towards carbon neutrality: A critical …

TM Lee, JY Lin, TH Tsai, RY Yang, IS Ng - Bioresource technology, 2023 - Elsevier
Carbon dioxide is the major greenhouse gas and regards as the critical issue of global
warming and climate changes. The inconspicuous microalgae are responsible for 40% of …

[HTML][HTML] Delivery of RNAs to specific organs by lipid nanoparticles for gene therapy

K Godbout, JP Tremblay - Pharmaceutics, 2022 - mdpi.com
Gene therapy holds great promise in the treatment of genetic diseases. It is now possible to
make DNA modifications using the CRISPR system. However, a major problem remains: the …